JP2008525317A5 - - Google Patents

Download PDF

Info

Publication number
JP2008525317A5
JP2008525317A5 JP2007542970A JP2007542970A JP2008525317A5 JP 2008525317 A5 JP2008525317 A5 JP 2008525317A5 JP 2007542970 A JP2007542970 A JP 2007542970A JP 2007542970 A JP2007542970 A JP 2007542970A JP 2008525317 A5 JP2008525317 A5 JP 2008525317A5
Authority
JP
Japan
Prior art keywords
pregnane
diol
3beta
beta
5beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007542970A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008525317A (ja
JP4914368B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2005/001671 external-priority patent/WO2006054938A1/en
Publication of JP2008525317A publication Critical patent/JP2008525317A/ja
Publication of JP2008525317A5 publication Critical patent/JP2008525317A5/ja
Application granted granted Critical
Publication of JP4914368B2 publication Critical patent/JP4914368B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007542970A 2004-11-18 2005-11-07 Ｇａｂａ−ステロイド拮抗剤およびｃｎｓ疾患の治療のためのその使用 Expired - Fee Related JP4914368B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62951104P 2004-11-18 2004-11-18
US60/629,511 2004-11-18
PCT/SE2005/001671 WO2006054938A1 (en) 2004-11-18 2005-11-07 Gaba-steroid antagonists and their use for the treatment of cns disorders

Publications (3)

Publication Number Publication Date
JP2008525317A JP2008525317A (ja) 2008-07-17
JP2008525317A5 true JP2008525317A5 (https=) 2008-12-25
JP4914368B2 JP4914368B2 (ja) 2012-04-11

Family

ID=36407411

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007542970A Expired - Fee Related JP4914368B2 (ja) 2004-11-18 2005-11-07 Ｇａｂａ−ステロイド拮抗剤およびｃｎｓ疾患の治療のためのその使用

Country Status (11)

Country Link
US (2) US8114860B2 (https=)
EP (1) EP1812009B1 (https=)
JP (1) JP4914368B2 (https=)
CN (1) CN101076340B (https=)
AU (1) AU2005307151B2 (https=)
BR (1) BRPI0518359A2 (https=)
CA (1) CA2585359C (https=)
DK (1) DK1812009T3 (https=)
ES (1) ES2423493T3 (https=)
MX (1) MX2007006032A (https=)
WO (1) WO2006054938A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101076340B (zh) 2004-11-18 2011-01-12 梅克芳股份公司 Gaba-类固醇拮抗剂及其治疗cns障碍的用途
DK2792681T3 (en) * 2006-11-21 2017-01-23 Umecrine Ab Use of Pregnancy and Androstan Steroids in the Preparation of a Pharmaceutical Composition for the Treatment of CNS Disorders.
CN101585862B (zh) * 2008-05-20 2014-12-17 梅克芳股份公司 甾族化合物
US20110086828A1 (en) * 2009-10-07 2011-04-14 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Treatment of alcohol abuse and alcoholism using modulators of neurosteroid binding sites on gabaa receptors
RU2012133627A (ru) 2010-01-14 2014-04-20 Умекрине Муд Аб Фармацевтическая композиция, содержащая 3-бета-гидрокси-5-альфа-прегнан-20-он, с улучшенными свойствами хранения и растворимости
EP4472435A1 (en) 2022-02-04 2024-12-11 Rousselot BV Use of collagen hydrolysate in prevention and/or treatment of food craving

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614499A (en) * 1985-04-29 1986-09-30 Universite Laval Simulator for use as a neurosurgical aid in determining potential paths for the implantation of probes through the human body
AU756001B2 (en) * 1998-03-11 2003-01-02 Umecrine Mood Ab Epiallopregnanolone in the treatment of CNS disorders
FR2806303B1 (fr) 2000-03-17 2002-09-27 Inst Nat Sante Rech Med Composes capables de se lier a des proteines constituantes ou associees aux elements du cytosquelette et leurs applications pour la fabrication de medicaments
US20030125311A1 (en) * 2000-03-17 2003-07-03 Etienne-Emile Baulieu Compounds capable of binding with the cytoskeleton
SE0104423D0 (sv) * 2001-12-27 2001-12-27 Umecrine Ab Pregnane steroids and their use in the treatment of CNS disorders
CN101076340B (zh) * 2004-11-18 2011-01-12 梅克芳股份公司 Gaba-类固醇拮抗剂及其治疗cns障碍的用途

Similar Documents

Publication Publication Date Title
JP2014506321A5 (https=)
JP2014528474A5 (https=)
JP2014515763A5 (https=)
WO2008050329A3 (en) Novel sirnas and methods of use thereof
EP2331095A4 (en) CYNURENINE-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND METHOD OF USE THEREOF
JP2009541348A5 (https=)
HK1199726A1 (en) Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
MA30290B1 (fr) Therapie antitumorale a l'aide d'un anticorps contre le facteur de croissance endotheliale vasculaire et d'un anticorps contre le recepteur du facteur de croissance epitheliale humain de type 2
HK1198619A1 (en) Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
JP7844340B2 (ja) 急性肺傷害の治療のための５－アミノ－２，３－ジヒドロ－１，４－フタラジンジオン
CN110114083A (zh) 一种预防和治疗脂肪肝的方法
BRPI0806392A8 (pt) uso de aclidínio, aclidínio, método de tratamento ou prevenção e composição farmacêutica
ATE421325T1 (de) Kombination von methylxanthinverbindungen und steroiden zur behandlung chronischer atemwegserkrankungen
JP2015505564A5 (https=)
JP2010500370A5 (https=)
JP2013231087A5 (https=)
JP2014510064A5 (https=)
WO2011151722A3 (en) Methods and compositions for oral pharmaceutical therapy
WO2010023482A3 (en) Therapeutic antibody
CN115697386A (zh) 一种治疗帕金森病的方法和药物
WO2008012796A3 (en) Pharmaceutical compositions comprising ccl2 and use of same for the treatment of inflammation
JP2008525317A5 (https=)
Chung et al. Effects of JSOG-6 on protection against bone loss in ovariectomized mice through regulation of osteoblast differentiation and osteoclast formation
JP2019529569A5 (https=)
JP2015515974A5 (https=)